SEOUL, South Korea, June 17, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export ...
WASHINGTON — An at-home COVID-19 testing kit is being recalled for failing to meet FDA requirements. The lack of FDA approval means that there is not sufficient data demonstrating that the test's ...
South Korean billionaire Cho Young-sik’s SD Biosensor and Seoul-based private equity firm SJL Partners said Thursday that they are acquiring Nasdaq-listed diagnostics company Meridian Bioscience for ...
SUWON, South Korea--(BUSINESS WIRE)--SD Biosensor, Inc., a global in-vitro diagnostics company, is voluntarily recalling its STANDARD Q COVID-19 Ag Home Test in the United States, due to confirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results